AzTrials
AzTrials

Colles FracturePhase 1/2NCT01561573

Ultrasound Assisted Distal Radius Fracture Reduction

A Phase 1/2 study testing Point of care ultrasound in people with Colles Fracture and Point of Care Ultrasound, run by University of British Columbia at 8 sites in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

PURPOSE: to evaluate the utility of bedside ultrasound performed by emergency physicians in the evaluation and reduction of colles fractures as compared with traditional pre and post reduction radiographs. Read more about this study

Who is it for?
Ages 19 years and older
What is being tested?
Point of care ultrasound
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
8 sitesCanada
Study dates
Apr 2012to Dec 2012
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • > 19 years old
  • Able to provide voluntary and informed consent
  • Distal radius fracture is the main traumatic injury
  • Planned reduction to be performed by the EP
  • Treating EP trained to perform EU for fractures OR one of the study authors available to perform EU

Who cannot join

  • < 19 years old
  • Patient unable to provide voluntary and informed consent
  • Distal radius fracture is only one of several significant injuries
  • No reduction to be performed by the EP
  • EP not trained to perform EU for fractures AND no study author available to perform EU

Trial locations and contacts

8 sites in 1 country.

Andrew Skinner, MD contact

6046197384

8 sites in 1 country

Canada8 sites, 8 recruiting
  • Foothills Medical Center

    Calgary, Alberta, T2N2T9

    Mark Bromley, MD, markobromley@gmail.com

    Not yet recruiting
  • Dartmouth General Hospital

    Dartmouth, Nova Scotia, B2Y3S3

    Chuck Wurster, MD, cwurster@me.com

    Not yet recruiting
  • Sudbury Regional Hospital

    Greater Sudbury, Ontario, P3E5J1

    Steve Socransky, MD, 7055618760

    Steve Socransky, MD

    Recruiting
  • Namnaimo General Hospital

    Nanaimo, British Columbia, V9S 2B7

    Ben Ho, MD, hoben@shaw.ca

    Not yet recruiting
  • Saint John Regional Hospital

    Saint John, New Brunswick, E2L4L2

    Paul Atkinson, MD, pandjatkinson@googlemail.com

    Recruiting
  • St. John's Health Science Center

    St. John's, Newfoundland and Labrador, A1B 3V6

    Andrew Smith, MD, ajjsmith1@yahoo.com

    Recruiting
  • Toronto East General Hospital

    Toronto, Ontario, M4C3E7

    Paul Hannam, MD, phann@tegh.on.ca

    Not yet recruiting
  • St. Paul's Hospital

    Vancouver, British Columbia, V6Z1Y6

    Andrew Skinner, MD, 6046197384

    Andrew Skinner, MD

    Recruiting

Other trials in Canada

About this study

PURPOSE: to evaluate the utility of bedside ultrasound performed by emergency physicians in the evaluation and reduction of colles fractures as compared with traditional pre and post reduction radiographs. With the objectives of assessing Emergency Ultrasounds (EU) utility in guiding reduction attempts of Colles fractures and to compare EU to x-ray for the final assessment of reduction adequacy.

Read the detailed description

The reduction of fractures is a commonly performed procedure in emergency departments (EDs). In most Canadian EDs, reductions are performed by emergency physicians (EPs). The distal radius fracture is the most common fracture requiring reduction. Fracture reduction is time-consuming with several steps required: initial evaluation including x-ray, equipment and personnel gathering, sedation and/or local anesthesia, reduction attempt(s) and splinting/casting, and post-reduction x-rays, with subsequent patient reassessment. These steps have a negative effect on ED patient throughput. Subsequent to the reduction attempt(s), the patient is sent for x-ray often with uncertainty regarding the reduction success. Fluoroscopy is generally not an option for the EP in evaluating accuracy of reduction. If the reduction is not adequate, further reduction attempts are needed. This utilizes more resources, either in the ED or orthopedic clinic or operating room, depending on where further reduction attempts are made.

Emergency ultrasound (EU) in Canada has become a well-established part of emergency medical practice in recent years as evidenced by the latest position statement of the Canadian Association of Emergency Physicians (http://caep.ca/template.asp?id=B5283F4158FB471AA56E480D6277C1AC) and the development of the Canadian Emergency Ultrasound Society (www.ceus.ca). A growing body of literature has shown the utility of EU in the diagnosis and reduction of fractures (1-6). A recent case report (7) showed that EU can be used to aid Colles fracture reduction. Similar to fluoroscopy, EU may be a fast and accurate method of determining successful fracture reduction. Unlike fluoroscopy, EU is available immediately in the ED. EU may also obviate the need for the post-reduction x-ray, particularly in the setting where the patient will have yet another x-ray at the time of orthopedic follow-up to evaluate for interval loss of reduction. Thus, EU has the potential to significantly reduce time to discharge.

Our study has the following objectives:

  • To assess EU utility for guiding reduction attempts of distal radius fractures.
  • To compare EU to x-ray for the final assessment of reduction adequacy.
Being tested
Point of care ultrasound
Keywords
Point of Care Ultrasound, Emergency Ultrasound, Colles Fracture, Fracture Reduction, Bedside Ultrasound
Medical subject headings
Colles' Fracture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Point of care ultrasoundDevice

    Also called Ultrasound Machines used in the study will include, Sonosite micromaxx, Sonosite M-Turbo, Ultrasonix Sonixtouch

    A bedside ultrasound machine will be used to image the colles fracture during the fracture reduction process.

Study groups in NCT01561573
Study groupRoleWhat they receive
Ultrasound colles fractureOtherThis is a single arm study
Receives: Device: Point of care ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy of Point of care ultrasound in Identifying colles fracture reduction

    Physicians performing Bedside ultrasound of colles fractures will be asked to complete likert scales on the adequacy of fracture reduction with ultrasound

    Measured: 1 year

Secondary outcomes (2)
  1. Number of reduction attempts affected by ultrasound

    The physician is asked to record the number of fracture reduction attempts as guided by the ultrasound image before and after the post reduction X-ray

    Measured: 1 year

  2. Time to imaging

    The physician performing the bedside ultrasound will record the time on completion of the bedside ultrasound and the time of completion of the post reduction X-ray

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2012 (estimated)
  2. Study startApr 2012
  3. Primary completionDec 2012 (estimated)
  4. Study completionDec 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
136 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01561573
Sponsor's protocol ID
SPH-POCUS-2012
Status last verified
Apr 2012
First submitted
16 Mar 2012
Last updated
24 Apr 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Point of care ultrasound in people with Colles Fracture and Point of Care Ultrasound, run by University of British Columbia at 8 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Apr 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrew Skinner, MD (6046197384), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy of Point of care ultrasound in Identifying colles fracture reduction (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in